VAERS reports by lot

GSK Varicella/Shingles lot NE3TG: VAERS reports

65 VAERS reports list lot NE3TG as a GSK Varicella/Shingles vaccine, received between 2019-05-19 and 2022-11-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
65
Reports
6%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction6026%
General / Systemic (non-local)4821%
Musculoskeletal2812%
Dermatological (non-injection-site)2812%
Neurological2511%
Gastrointestinal146%
Allergic / Anaphylactic125%
Cardiac / Cardiovascular63%
Respiratory52%
Psychiatric / Neuropsychiatric52%
Thrombotic / Hematological21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Minnesota6
Colorado5
North Dakota4
California4
Pennsylvania3
Montana3
Washington3
Utah3
Iowa3
Idaho2
Ohio2
Maryland2

Reports by month received

2019-0511
2019-0623
2019-0710
2019-0811
2019-093
2019-112
2020-011
2020-022
2020-071
2022-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.